Drawing for AAV 3.0

USPTO serial 86664357

AAV 3.0

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
CHHINA, KARANENDRA S
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AAV 3.0?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Gene therapy assays; gene therapy reagents; gene therapy preparations; nucleic acid delivery assays; nucleic acid delivery reagents; nucleic acid delivery preparations; viral vectors; gene therapy vectors; nucleic acid delivery vectors; cells and tissues transformed by viral vectors, gene therapy vectors, and nucleic acid delivery vectorsACTIVE
005Chemical preparations for gene therapy for treating genetic disorders; viral medicines; gene therapy medicines; nucleic acid delivery medicines; viral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for use in nucleic acid-based therapy, gene therapy and cell therapy in the treatment of human diseasesACTIVE
042Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific and medical research and development, namely, laboratory research in the field of gene therapy vectors for medical and research purposes; genetic engineering biotechnology services, namely, research and development of new technology in the field of biotechnology; product development services related to gene therapy products and instruments; consultation services in the fields of medical and scientific research in the field of gene therapyACTIVE
044Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of human diseasesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 10, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 10, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 16, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 15, 2018EX5GSOU EXTENSION 5 GRANTED
Oct 15, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 5, 2018EXT5SOU EXTENSION 5 FILED
Oct 5, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 13, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 9, 2018EX4GSOU EXTENSION 4 GRANTED
Mar 9, 2018EXT4SOU EXTENSION 4 FILED
Mar 9, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 1, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 30, 2017EX3GSOU EXTENSION 3 GRANTED
Oct 30, 2017EXT3SOU EXTENSION 3 FILED
Oct 30, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 26, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 24, 2017EX2GSOU EXTENSION 2 GRANTED
Apr 24, 2017EXT2SOU EXTENSION 2 FILED
Apr 24, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 24, 2017CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 24, 2017COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 25, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 21, 2016EX1GSOU EXTENSION 1 GRANTED
Oct 21, 2016EXT1SOU EXTENSION 1 FILED
Oct 21, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 10, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 15, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 15, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 24, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 29, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2016XAECEXAMINER'S AMENDMENT ENTERED
Jan 29, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 29, 2016GNEAEXAMINERS AMENDMENT E-MAILED
Jan 29, 2016CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 1, 2015GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 1, 2015GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 1, 2015CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 21, 2015DOCKASSIGNED TO EXAMINER
Jun 23, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED
Jun 22, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 19, 2015NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance